EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Epizyme Names Sanofi Cancer Exec New COO

Xconomy Boston — 

Cambridge, MA-based Epizyme (NASDAQ: EPZM) has named Matthew Ros its new chief operating officer. Ros most recently ran Sanofi’s oncology business, and led Genzyme’s franchise in pompe disease before that.